{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Mohr K"],"funding":["Johannes Gutenberg University Mainz","Bayer AG","Federal Ministry of Education and Research"],"pagination":["334-342"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12045087"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(3)"],"pubmed_abstract":["<h4>Aims</h4>Patients surviving acute pulmonary embolism (PE) necessitate long-term treatment and follow-up. We estimated, the chronic economic impact of PE on the German healthcare system.<h4>Methods and results</h4>We calculated the direct cost of illness during the first year after discharge for the index PE, analysing data from a multicentre prospective cohort study in Germany. Main and accompanying readmission diagnoses were used to calculate DRG-based hospital reimbursements; anticoagulation costs were estimated from the exact treatment duration and each drug's unique national identifier; and outpatient post-PE care costs from guidelines-recommended algorithms and national reimbursement catalogues. Of 1017 patients enrolled at 17 centres, 958 (94%) completed ≥3-month follow-up; of th"],"journal":["European heart journal. Quality of care & clinical outcomes"],"pubmed_title":["Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study."],"pmcid":["PMC12045087"],"funding_grant_id":["006_PH/Schau(32690)","FOCUS17257","01EO1003","01EO1503"],"pubmed_authors":["Valerio L","Wachter R","Trudzinski F","Neusius T","Leuchte HH","Rosenkranz S","Holtz I","Konstantinides SV","Mavromanoli AC","Kaberich A","Klok FA","Binder H","FOCUS Investigators","Otto S","Hobohm L","Heier EM","Pohl C","Emge-Rossa D","Thabaret K","Opitz C","Martin N","Halank M","Tausche K","Ewert R","Keller K","Horn A","Fischer B","Schuler K","Berger P","Landmesser A","Salkic A","Hoeper MM","Seyfarth HJ","Mildenberger P","Kaier K","Tayler S","Meyer FJ","Gerhardt F","Schroder B","Fistera D","Hennig A","Barton J","Sentler C","Barco S","Mohr K","Grunig E","Grgic A","Faehling M","Mayer E","Gun S","Abele C","Geistert S","Bruch L","Wilkens H","Neurohr C","Jakel D","Hellenkamp K","Held M","George U","Rink T","Schmidtmann I","Egenlauf B","Freise J","Farmakis IT","Pieper J","Ghofrani HA","Bressem I","Christodoulou KC","Schmidt KH","Wild PS","Blaich B","Rudolph J","Schulte M","Becker D"],"additional_accession":[]},"is_claimable":false,"name":"Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study.","description":"<h4>Aims</h4>Patients surviving acute pulmonary embolism (PE) necessitate long-term treatment and follow-up. We estimated, the chronic economic impact of PE on the German healthcare system.<h4>Methods and results</h4>We calculated the direct cost of illness during the first year after discharge for the index PE, analysing data from a multicentre prospective cohort study in Germany. Main and accompanying readmission diagnoses were used to calculate DRG-based hospital reimbursements; anticoagulation costs were estimated from the exact treatment duration and each drug's unique national identifier; and outpatient post-PE care costs from guidelines-recommended algorithms and national reimbursement catalogues. Of 1017 patients enrolled at 17 centres, 958 (94%) completed ≥3-month follow-up; of th","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 May","modification":"2025-07-08T03:12:48.807Z","creation":"2025-07-08T03:12:48.807Z"},"accession":"S-EPMC12045087","cross_references":{"pubmed":["38950900"],"doi":["10.1093/ehjqcco/qcae050"]}}